ereprof. dr. Johan Vande Walle
Show
Sort by
-
- Conference Paper
- C3
- open access
Eculizumab inhibits thrombotic microangiopathy and improves renal function in pediatric patients with atypical hemolytic uremic syndrome
-
Factors influencing choice of renal replacement therapy in European paediatric nephrology units
-
Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis
-
- Conference Paper
- C3
- open access
An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: initial patient characteristics
-
Continentie problematiek
-
Mediquality project
-
Questions and answers
-
The explanation of the past experiences and the future perspectives of ICCS educational issues
-
Alternative treatments (accupuncture, Tens, etc) do they work?
-
Gender differences in antidiuretic function